This report was recently updated on May 9 2024 with the latest and most recent
market numbers
Global Alpha-Particle Radiotherapy Market Size, Trends & Analysis - Forecasts to 2029 By Type of Radioisotope (Actinium-225, Bismuth-213, and Lead-212), By Application (Prostate Cancer, Leukemia, Brain Cancer, Bone Metastases, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global alpha-particle radiotherapy market is projected to grow at a CAGR of 9.8% from 2024 to 2029.
As cancer rates increase globally, there is a rising demand for more effective treatment alternatives. Alpha-particle radiation is gaining popularity because it provides a promising way of targeting and killing cancer cells. Its precise method reduces injury to healthy tissue, which may improve patient outcomes. As the benefits become more widely known, healthcare providers and people increasingly view it as a viable therapy choice. This interest in alpha-particle radiation helps to drive its use in clinical settings, meeting the demand for novel cancer therapies and altering the healthcare environment.
According to the World Health Organization, in 2022, globally around 20 million new cancer cases were diagnosed, resulting in 9.7 million deaths. The estimated number of individuals surviving at least five years post-cancer diagnosis was approximately 53.5 million. Around one in five individuals develop cancer during their lifetime, with cancer accounting for the demise of about one in nine men and one in twelve women.
Technological advancements have greatly improved alpha-particle radiation procedures, making them more precise and effective. These advancements allow for more precise tumor targeting while limiting injury to other related healthy tissues, boosting therapeutic efficacy and safety overall. Such developments demonstrate a dedication to improving cancer therapies through medical technology innovation, potentially benefiting both patients and healthcare providers.
Numerous countries are increasing their investments in healthcare infrastructure, including facilities capable of modern cancer treatments such as alpha-particle radiation. This expansion intends to improve access to such treatments, which could boost market growth. The upgraded healthcare infrastructure attempts to fulfill the increasing demand for innovative therapies and make them more accessible to a larger population. This strategic investment boosts healthcare systems, allowing patients to get cutting-edge treatments while potentially expanding the market for alpha-particle radiation and related technology.
However, the high expenses of alpha-particle radiation equipment, treatment procedures, and maintenance may limit its adoption, particularly in regions with limited healthcare budgets or patients facing financial restraints.
The Actinium-225 segment is expected to hold the largest share of the market during the forecast period. The segment growth is due to its unique qualities, such as high linear energy transfer and short half-life, which make it highly effective at targeting cancer cells while causing minimal damage to healthy tissue. Furthermore, continuous research and clinical studies into Actinium-225-based therapeutics for various malignancies contribute to market growth.
The Lead-212 segment is expected to be the fastest-growing segment in the market from 2024-2029. The growth is attributed to its good qualities for targeted cancer therapy. Lead-212 has a longer half-life than other radioisotopes, allowing for prolonged therapeutic effects and increasing efficacy. Furthermore, continuous advances in radiopharmaceutical research, notably the development of novel targeting agents and delivery systems for Lead-212, are likely to drive its adoption.
The bone metastases segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. The growth is attributed to the high prevalence of bone metastases in several cancer types, including breast, prostate, and lung cancer. Alpha-particle radiation is a promising treatment option for bone metastases because it may target and destroy cancer cells in the bone while preserving healthy tissue.
The prostate cancer segment is expected to hold the largest share of the market. The segment growth is due to the high prevalence of prostate cancer and the growing use of alpha-particle radiation as a primary treatment option. The capacity of alpha-particle radiation to accurately target prostate cancers while avoiding damage to surrounding tissues makes it highly effective in treating this kind of cancer, contributing to its market growth.
North America is expected to be the largest region in the market. The primary reasons boosting the market growth in this region include robust healthcare infrastructure, high healthcare spending, and a strong presence of key industry participants. Furthermore, favorable reimbursement policies and increased investments in R&D drive market expansion in this region. Furthermore, a rising cancer prevalence and an aging population drive demand for novel cancer medicines, contributing to North America's market dominance.
Asia Pacific is predicted to witness rapid growth during the forecast period. The regional market growth is due to rising healthcare costs, increased cancer prevalence, and improved access to innovative medical technology. Furthermore, supportive government initiatives and increased knowledge regarding alpha-particle radiation help to drive market growth in the region. With a vast patient population and expanding healthcare infrastructure, Asia Pacific is emerging as a key market for alpha-particle radiotherapy.
Alpha Tau Medical, Bayer, Alpha-9 Theranostics, Mariana Oncology, RayzeBio, ARTBIO, Fusion Pharmaceuticals, Aktis Oncology, Radiomedix, Inc., and Atley Solutions, among others, are some of the key players operating in the global alpha-particle radiotherapy market.
Please note: This is not an exhaustive list of companies profiled in the report.
In January 2023, Orano Med initiated a Phase I trial for its alpha radioligand therapy, 212Pb-GRPR, targeting solid tumors expressing the gastrin-releasing peptide receptor (GRPR). This innovative therapy aims to enhance outcomes for patients with advanced solid tumors by leveraging the short-range cell-killing capabilities of alpha-emitting radioisotopes, potentially minimizing toxicity to surrounding healthy cells. The trial, which involves dose escalation and expansion phases, will evaluate safety, tolerability, and efficacy endpoints in approximately 30 patients with advanced solid tumors.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL ALPHA-PARTICLE RADIOTHERAPY MARKET, BY APPLICATION
4.1 Introduction
4.2 Alpha-Particle Radiotherapy Market: Application Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Prostate Cancer
4.4.1 Prostate Cancer Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Leukemia
4.5.1 Leukemia Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Brain Cancer
4.6.1 Brain Cancer Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Bone Metastases
4.7.1 Bone Metastases Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Others
4.8.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL ALPHA-PARTICLE RADIOTHERAPY MARKET, BY TYPE OF RADIOISOTOPE
5.1 Introduction
5.2 Alpha-Particle Radiotherapy Market: Type of Radioisotope Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Actinium-225
5.4.1 Actinium-225 Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Bismuth-213
5.5.1 Bismuth-213 Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Lead-212
5.6.1 Lead-212 Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL ALPHA-PARTICLE RADIOTHERAPY MARKET, BY REGION
6.1 Introduction
6.2 North America Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Application
6.2.2 By Type of Radioisotope
6.2.3 By Country
6.2.3.1 U.S. Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Application
6.2.3.1.2 By Type of Radioisotope
6.2.3.2 Canada Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Application
6.2.3.2.2 By Type of Radioisotope
6.2.3.3 Mexico Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Application
6.2.3.3.2 By Type of Radioisotope
6.3 Europe Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Application
6.3.2 By Type of Radioisotope
6.3.3 By Country
6.3.3.1 Germany Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Application
6.3.3.1.2 By Type of Radioisotope
6.3.3.2 U.K. Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Application
6.3.3.2.2 By Type of Radioisotope
6.3.3.3 France Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Application
6.3.3.3.2 By Type of Radioisotope
6.3.3.4 Italy Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Application
6.3.3.4.2 By Type of Radioisotope
6.3.3.5 Spain Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Application
6.3.3.5.2 By Type of Radioisotope
6.3.3.6 Netherlands Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Application
6.3.3.6.2 By Type of Radioisotope
6.3.3.7 Rest of Europe Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Application
6.3.3.6.2 By Type of Radioisotope
6.4 Asia Pacific Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Application
6.4.2 By Type of Radioisotope
6.4.3 By Country
6.4.3.1 China Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Application
6.4.3.1.2 By Type of Radioisotope
6.4.3.2 Japan Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Application
6.4.3.2.2 By Type of Radioisotope
6.4.3.3 India Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Application
6.4.3.3.2 By Type of Radioisotope
6.4.3.4 South Korea Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Application
6.4.3.4.2 By Type of Radioisotope
6.4.3.5 Singapore Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Application
6.4.3.5.2 By Type of Radioisotope
6.4.3.6 Malaysia Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Application
6.4.3.6.2 By Type of Radioisotope
6.4.3.7 Thailand Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Application
6.4.3.6.2 By Type of Radioisotope
6.4.3.8 Indonesia Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Application
6.4.3.7.2 By Type of Radioisotope
6.4.3.9 Vietnam Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Application
6.4.3.8.2 By Type of Radioisotope
6.4.3.10 Taiwan Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Application
6.4.3.10.2 By Type of Radioisotope
6.4.3.11 Rest of Asia Pacific Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Application
6.4.3.11.2 By Type of Radioisotope
6.5 Middle East and Africa Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Application
6.5.2 By Type of Radioisotope
6.5.3 By Country
6.5.3.1 Saudi Arabia Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Application
6.5.3.1.2 By Type of Radioisotope
6.5.3.2 U.A.E. Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Application
6.5.3.2.2 By Type of Radioisotope
6.5.3.3 Israel Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Application
6.5.3.3.2 By Type of Radioisotope
6.5.3.4 South Africa Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Application
6.5.3.4.2 By Type of Radioisotope
6.5.3.5 Rest of Middle East and Africa Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Application
6.5.3.5.2 By Type of Radioisotope
6.6 Central and South America Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Application
6.6.2 By Type of Radioisotope
6.6.3 By Country
6.6.3.1 Brazil Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Application
6.6.3.1.2 By Type of Radioisotope
6.6.3.2 Argentina Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Application
6.6.3.2.2 By Type of Radioisotope
6.6.3.3 Chile Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Application
6.6.3.3.2 By Type of Radioisotope
6.6.3.3 Rest of Central and South America Alpha-Particle Radiotherapy Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Application
6.6.3.3.2 By Type of Radioisotope
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Alpha Tau Medical
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Bayer
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Alpha-9 Theranostics
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Mariana Oncology
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 RayzeBio
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 ARTBIO
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Fusion Pharmaceuticals
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Aktis Oncology
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Radiomedix, Inc.
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Atley Solutions
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
2 Prostate Cancer Market, By Region, 2021-2029 (USD Mllion)
3 Leukemia Market, By Region, 2021-2029 (USD Mllion)
4 Brain Cancer Market, By Region, 2021-2029 (USD Mllion)
5 Bone Metastases Market, By Region, 2021-2029 (USD Mllion)
6 Others Market, By Region, 2021-2029 (USD Mllion)
7 Global Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
8 Actinium-225 Market, By Region, 2021-2029 (USD Mllion)
9 Bismuth-213 Market, By Region, 2021-2029 (USD Mllion)
10 Lead-212 Market, By Region, 2021-2029 (USD Mllion)
11 Regional Analysis, 2021-2029 (USD Mllion)
12 North America Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
13 North America Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
14 North America Alpha-Particle Radiotherapy Market, By COUNTRY, 2021-2029 (USD Mllion)
15 U.S. Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
16 U.S. Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
17 Canada Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
18 Canada Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
19 Mexico Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
20 Mexico Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
21 Europe Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
22 Europe Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
23 Europe Alpha-Particle Radiotherapy Market, By Country, 2021-2029 (USD Mllion)
24 Germany Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
25 Germany Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
26 U.K. Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
27 U.K. Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
28 France Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
29 France Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
30 Italy Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
31 Italy Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
32 Spain Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
33 Spain Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
34 Netherlands Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
35 Netherlands Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
36 Rest Of Europe Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
37 Rest Of Europe Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
38 Asia Pacific Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
39 Asia Pacific Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
40 Asia Pacific Alpha-Particle Radiotherapy Market, By Country, 2021-2029 (USD Mllion)
41 China Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
42 China Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
43 Japan Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
44 Japan Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
45 India Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
46 India Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
47 South Korea Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
48 South Korea Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
49 Singapore Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
50 Singapore Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
51 Thailand Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
52 Thailand Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
53 Malaysia Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
54 Malaysia Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
55 Indonesia Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
56 Indonesia Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
57 Vietnam Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
58 Vietnam Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
59 Taiwan Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
60 Taiwan Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
61 Rest of APAC Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
62 Rest of APAC Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
63 Middle East and Africa Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
64 Middle East and Africa Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
65 Middle East and Africa Alpha-Particle Radiotherapy Market, By Country, 2021-2029 (USD Mllion)
66 Saudi Arabia Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
67 Saudi Arabia Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
68 UAE Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
69 UAE Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
70 Israel Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
71 Israel Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
72 South Africa Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
73 South Africa Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
74 Rest Of Middle East and Africa Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
75 Rest Of Middle East and Africa Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
76 Central and South America Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
77 Central and South America Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
78 Central and South America Alpha-Particle Radiotherapy Market, By Country, 2021-2029 (USD Mllion)
79 Brazil Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
80 Brazil Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
81 Chile Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
82 Chile Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
83 Argentina Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
84 Argentina Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
85 Rest Of Central and South America Alpha-Particle Radiotherapy Market, By Application, 2021-2029 (USD Mllion)
86 Rest Of Central and South America Alpha-Particle Radiotherapy Market, By Type of Radioisotope, 2021-2029 (USD Mllion)
87 Alpha Tau Medical: Products & Services Offering
88 Bayer: Products & Services Offering
89 Alpha-9 Theranostics: Products & Services Offering
90 Mariana Oncology: Products & Services Offering
91 RayzeBio: Products & Services Offering
92 ARTBIO: Products & Services Offering
93 Fusion Pharmaceuticals : Products & Services Offering
94 Aktis Oncology: Products & Services Offering
95 Radiomedix, Inc., Inc: Products & Services Offering
96 Host Analytics: Products & Services Offering
97 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Alpha-Particle Radiotherapy Market Overview
2 Global Alpha-Particle Radiotherapy Market Value From 2021-2029 (USD Mllion)
3 Global Alpha-Particle Radiotherapy Market Share, By Application (2023)
4 Global Alpha-Particle Radiotherapy Market Share, By Type of Radioisotope (2023)
5 Global Alpha-Particle Radiotherapy Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Alpha-Particle Radiotherapy Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Alpha-Particle Radiotherapy Market
10 Impact Of Challenges On The Global Alpha-Particle Radiotherapy Market
11 Porter’s Five Forces Analysis
12 Global Alpha-Particle Radiotherapy Market: By Application Scope Key Takeaways
13 Global Alpha-Particle Radiotherapy Market, By Application Segment: Revenue Growth Analysis
14 Prostate Cancer Market, By Region, 2021-2029 (USD Mllion)
15 Leukemia Market, By Region, 2021-2029 (USD Mllion)
16 Brain Cancer Market, By Region, 2021-2029 (USD Mllion)
17 Bone Metastases Market, By Region, 2021-2029 (USD Mllion)
18 Others Market, By Region, 2021-2029 (USD Mllion)
19 Global Alpha-Particle Radiotherapy Market: By Type of Radioisotope Scope Key Takeaways
20 Global Alpha-Particle Radiotherapy Market, By Type of Radioisotope Segment: Revenue Growth Analysis
21 Actinium-225 Market, By Region, 2021-2029 (USD Mllion)
22 Bismuth-213 Market, By Region, 2021-2029 (USD Mllion)
23 Lead-212 Market, By Region, 2021-2029 (USD Mllion)
24 Regional Segment: Revenue Growth Analysis
25 Global Alpha-Particle Radiotherapy Market: Regional Analysis
26 North America Alpha-Particle Radiotherapy Market Overview
27 North America Alpha-Particle Radiotherapy Market, By Application
28 North America Alpha-Particle Radiotherapy Market, By Type of Radioisotope
29 North America Alpha-Particle Radiotherapy Market, By Country
30 U.S. Alpha-Particle Radiotherapy Market, By Application
31 U.S. Alpha-Particle Radiotherapy Market, By Type of Radioisotope
32 Canada Alpha-Particle Radiotherapy Market, By Application
33 Canada Alpha-Particle Radiotherapy Market, By Type of Radioisotope
34 Mexico Alpha-Particle Radiotherapy Market, By Application
35 Mexico Alpha-Particle Radiotherapy Market, By Type of Radioisotope
36 Four Quadrant Positioning Matrix
37 Company Market Share Analysis
38 Alpha Tau Medical: Company Snapshot
39 Alpha Tau Medical: SWOT Analysis
40 Alpha Tau Medical: Geographic Presence
41 Bayer: Company Snapshot
42 Bayer: SWOT Analysis
43 Bayer: Geographic Presence
44 Alpha-9 Theranostics: Company Snapshot
45 Alpha-9 Theranostics: SWOT Analysis
46 Alpha-9 Theranostics: Geographic Presence
47 Mariana Oncology: Company Snapshot
48 Mariana Oncology: Swot Analysis
49 Mariana Oncology: Geographic Presence
50 RayzeBio: Company Snapshot
51 RayzeBio: SWOT Analysis
52 RayzeBio: Geographic Presence
53 ARTBIO: Company Snapshot
54 ARTBIO: SWOT Analysis
55 ARTBIO: Geographic Presence
56 Fusion Pharmaceuticals : Company Snapshot
57 Fusion Pharmaceuticals : SWOT Analysis
58 Fusion Pharmaceuticals : Geographic Presence
59 Aktis Oncology: Company Snapshot
60 Aktis Oncology: SWOT Analysis
61 Aktis Oncology: Geographic Presence
62 Radiomedix, Inc., Inc.: Company Snapshot
63 Radiomedix, Inc., Inc.: SWOT Analysis
64 Radiomedix, Inc., Inc.: Geographic Presence
65 Host Analytics: Company Snapshot
66 Host Analytics: SWOT Analysis
67 Host Analytics: Geographic Presence
68 Other Companies: Company Snapshot
69 Other Companies: SWOT Analysis
70 Other Companies: Geographic Presence
The Global Alpha-Particle Radiotherapy Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Alpha-Particle Radiotherapy Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
